Nov.3,2019 – VGH Research Pavilion, Vancouver, Canada

TMFOX VENTURE PARTNERS is please to announce an Advisory Agreement to SONIC INCYTES MEDICAL CORP. A point of care startup founded in University of British Columbia in 2016.

With this Advisory Agreement, TMFOX VENTURE PARTNERS servers a member of Advisory Board and oversees overall strategy of accessing into China market, including market reserach, product/business model design, clinic trial and regulatory approval, deal structure , investments with viable funds(RMB Fund and USD FUND).

SONIC INCYTES, with its innovative technologies, provides MRI capability at hospitals, community hospitals, home doctor office, clinic, and healthcare examination center, and bring early detection and healthcare management solution to more than 400 million population across U.S.A and China market, especially for those who are suffering NAFLD.